A carregar...
Cost-Effectiveness of Dual Bronchodilator Indacaterol/Glycopyrronium for COPD Treatment in China
BACKGROUND: Indacaterol/glycopyrronium (IND/GLY) is a once-daily dual bronchodilator for long-term treatment of patients with chronic obstructive pulmonary disease (COPD). The efficacy and safety of IND/GLY have been proved before, but the cost-effectiveness is unknown in China. PURPOSE: This study...
Na minha lista:
| Publicado no: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7914055/ https://ncbi.nlm.nih.gov/pubmed/33654393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S276476 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|